Biotech · Private company · Gainesville, FL, US
Immunogenik, Inc.
Track this companyFree. Adds Immunogenik, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Advancing cancer therapy: Developing antibody blockade targeting a novel immune checkpoint, LAIR1/CD305Fiscal year 2025 · $399KNIH RePORTER 1R41CA298020-01 · fetched Nov 12, 2026
- Enhance Cancer Therapeutics with 3-in-1 CAR T CellsFiscal year 2025 · $399KNIH RePORTER 1R41CA301978-01 · fetched Nov 12, 2026